Structure 2011-11-09

Structural basis for μ-opioid receptor binding and activation.

Adrian W R Serohijos, Shuangye Yin, Feng Ding, Josee Gauthier, Dustin G Gibson, William Maixner, Nikolay V Dokholyan, Luda Diatchenko

Index: Structure 19(11) , 1683-90, (2011)

Full Text: HTML

Abstract

Opioids that stimulate the μ-opioid receptor (MOR1) are the most frequently prescribed and effective analgesics. Here we present a structural model of MOR1. Molecular dynamics simulations show a ligand-dependent increase in the conformational flexibility of the third intracellular loop that couples with the G protein complex. These simulations likewise identified residues that form frequent contacts with ligands. We validated the binding residues using site-directed mutagenesis coupled with radioligand binding and functional assays. The model was used to blindly screen a library of ∼1.2 million compounds. From the 34 compounds predicted to be strong binders, the top three candidates were examined using biochemical assays. One compound showed high efficacy and potency. Post hoc testing revealed this compound to be nalmefene, a potent clinically used antagonist, thus further validating the model. In summary, the MOR1 model provides a tool for elucidating the structural mechanism of ligand-initiated cell signaling and for screening novel analgesics.Copyright © 2011 Elsevier Ltd. All rights reserved.


Related Compounds

Related Articles:

Treatment of alcohol dependence: recent progress and reduction of consumption.

2014-12-01

[Minerva Med. 105(6) , 447-66, (2014)]

Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.

2014-05-14

[JAMA 311(18) , 1889-900, (2014)]

In vivo characterization of the opioid antagonist nalmefene in mice.

2010-04-10

[Life Sci. 86(15-16) , 624-30, (2010)]

A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.

2011-08-01

[Journal. of. Drugs in. Dermatology. 10(8) , 853-60, (2011)]

Nalmefene and its use in alcohol dependence.

2014-05-01

[Drugs Today (Barc) 50(5) , 347-55, (2014)]

More Articles...